Pascale Cornillet‐Lefèbvre

Author

Université de Reims Champagne-Ardenne ORCID

Also Known As

Cornillet-Lefebvre, P., Cornillet-Lefebvre, Pascale, P Cornillet-Lefebvre, P. CORNILLET‐LEFEBVRE, P. Cornillet-Lefebvre, P. Cornillet-Lefèbvre, P. Cornillet‐Lefèbvre, Pascale CORNILLET-LEFEBVRE, Pascale Cornillet-Lefebvre, Pascale Cornillet-Lefèbvre

109

Publications

4.3K

Citations

H-Index

Concepts

All Affiliations

Université de Reims Champagne-Ardenne Centre Hospitalier Universitaire de Reims Inserm Assistance Publique – Hôpitaux de Paris Centre National de la Recherche Scientifique

About

Pascale Cornillet‐Lefèbvre is an author at Université de Reims Champagne-Ardenne specializing in medicine, hematology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	989
2	Health Sciences	5	5	131
3	Public Health	1	1	12
4	Biochemistry	1	1	49
5	Biostatistics	1	1	121

Pascale Cornillet‐Lefèbvre

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
The MLL recombinome of acute leukemias in 2013 Claus Meyer, Jörg Hofmann, Thomas Burmeister, Leukemia	2013	506
Genotype–phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21 Robert Lyle, Frédérique Béna, Sarantis Gagos, European Journal of Human Genetics Down SyndromeArray CghCytogeneticsGenetic DisorderGenetics	2008	325
Indolent CD8-positive Lymphoid Proliferation of the Ear Tony Petrella, E. Maubec, Pascale Cornillet‐Lefèbvre, The American Journal of Surgical Pathology Lymphoid NeoplasiaAutoimmune DiseaseLymphocyte DevelopmentMedicineSuch Indolent Lesions	2007	179
High frequency of RUNX1 biallelic alteration in acute myeloid leukemia secondary to familial platelet disorder Claude Preudhomme, Aline Renneville, Violaine Bourdon, Blood	2009	167
Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody Nicolas Chapuis, Jérôme Tamburini, Pascale Cornillet‐Lefèbvre, Haematologica	2009	142
Constitutive phosphoinositide 3-kinase/Akt activation represents a favorable prognostic factor in de novo acute myelogenous leukemia patients Jérôme Tamburini, Caroline Elie, Valérie Bardet, Blood	2007	142
Leukemia : Official Journal of the Leukemia Society of America, Leukemia Research Fund, U.K Isabelle Luquet, Jia‐Qi Lai, Carole Barin, Leukemia SocietyHematological MalignancyMedicineMixed-phenotype Acute LeukemiaHematology	2008	129
A new Leukemia Prognostic Scoring System for refractory/relapsed adult acute myelogeneous leukaemia patients: a GOELAMS study Patrice Chevallier, Myriam Labopin, Pascal Turlure, Leukemia Hematological MalignancyPrognostic EvaluationMedicineMixed-phenotype Acute LeukemiaPrognosis	2011	121
Prospective long-term minimal residual disease monitoring using RQ-PCR in RUNX1-RUNX1T1-positive acute myeloid leukemia: results of the French CBF-2006 trial Christophe Willekens, Odile Blanchet, Aline Renneville, Haematologica	2015	109
Haematological spectrum and genotype-phenotype correlations in nine unrelated families with RUNX1 mutations from the French network on inherited platelet disorders Véronique Latger‐Cannard, Christophe Philippe, Alexandre Bouquet, Orphanet Journal of Rare Diseases	2016	101

Page 1